Inhibitors of the lyase activity of DNA polymerase β

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

One focus of our NCDDG program is the DNA repair enzyme DNA polymerase β. This enzyme serves an important protective role by participating in the repair of lesions to DNA caused by environmental and metabolic events. However, this enzyme is also believed to help repair the damage caused by agents employed as antitumor agents, such as bleomycin and cisplatin. In this sense, transient inhibition of the enzyme concomitant with antitumor therapy might improve the effectiveness of certain DNA damaging antitumor agents. Accordingly, we have been identifying naturally occurring inhibitors of DNA polymerase β. It is now known that there are two transformations mediated by polymerase β, namely a gap-filling polymerization from which the enzyme derives its name, as well as a lyase reaction that results in excision of the deoxyribose phosphate moiety at the site of the lesion. The lyase reaction is believed to be the rate-limiting step. This presentation summarizes the status of studies of identification of inhibitors of both activities.

Original languageEnglish (US)
Pages (from-to)68-77
Number of pages10
JournalPharmaceutical Biology
Volume41
Issue numberSUPPL.
StatePublished - 2003
Externally publishedYes

Fingerprint

Lyases
lyases
DNA-directed DNA polymerase
DNA-Directed DNA Polymerase
antineoplastic agents
Enzymes
enzymes
Antineoplastic Agents
Repair
DNA Repair Enzymes
Deoxyribose
Nucleic Acid Synthesis Inhibitors
cisplatin
enzyme inhibition
DNA
Bleomycin
DNA repair
Polymerization
polymerization
Cisplatin

Keywords

  • Adjuvant chemotherapy
  • Base excision repair
  • DNA polymerase β
  • Lyase inhibitors
  • Natural products
  • Polymerase inhibitors

ASJC Scopus subject areas

  • Plant Science
  • Medical Laboratory Technology
  • Clinical Biochemistry
  • Pharmacology
  • Drug Discovery
  • Pharmaceutical Science
  • Complementary and alternative medicine
  • Molecular Medicine

Cite this

Inhibitors of the lyase activity of DNA polymerase β. / Hecht, Sidney.

In: Pharmaceutical Biology, Vol. 41, No. SUPPL., 2003, p. 68-77.

Research output: Contribution to journalArticle

@article{43aad7715966446cafa1f1675e3d15b8,
title = "Inhibitors of the lyase activity of DNA polymerase β",
abstract = "One focus of our NCDDG program is the DNA repair enzyme DNA polymerase β. This enzyme serves an important protective role by participating in the repair of lesions to DNA caused by environmental and metabolic events. However, this enzyme is also believed to help repair the damage caused by agents employed as antitumor agents, such as bleomycin and cisplatin. In this sense, transient inhibition of the enzyme concomitant with antitumor therapy might improve the effectiveness of certain DNA damaging antitumor agents. Accordingly, we have been identifying naturally occurring inhibitors of DNA polymerase β. It is now known that there are two transformations mediated by polymerase β, namely a gap-filling polymerization from which the enzyme derives its name, as well as a lyase reaction that results in excision of the deoxyribose phosphate moiety at the site of the lesion. The lyase reaction is believed to be the rate-limiting step. This presentation summarizes the status of studies of identification of inhibitors of both activities.",
keywords = "Adjuvant chemotherapy, Base excision repair, DNA polymerase β, Lyase inhibitors, Natural products, Polymerase inhibitors",
author = "Sidney Hecht",
year = "2003",
language = "English (US)",
volume = "41",
pages = "68--77",
journal = "Pharmaceutical Biology",
issn = "1388-0209",
publisher = "Informa Healthcare",
number = "SUPPL.",

}

TY - JOUR

T1 - Inhibitors of the lyase activity of DNA polymerase β

AU - Hecht, Sidney

PY - 2003

Y1 - 2003

N2 - One focus of our NCDDG program is the DNA repair enzyme DNA polymerase β. This enzyme serves an important protective role by participating in the repair of lesions to DNA caused by environmental and metabolic events. However, this enzyme is also believed to help repair the damage caused by agents employed as antitumor agents, such as bleomycin and cisplatin. In this sense, transient inhibition of the enzyme concomitant with antitumor therapy might improve the effectiveness of certain DNA damaging antitumor agents. Accordingly, we have been identifying naturally occurring inhibitors of DNA polymerase β. It is now known that there are two transformations mediated by polymerase β, namely a gap-filling polymerization from which the enzyme derives its name, as well as a lyase reaction that results in excision of the deoxyribose phosphate moiety at the site of the lesion. The lyase reaction is believed to be the rate-limiting step. This presentation summarizes the status of studies of identification of inhibitors of both activities.

AB - One focus of our NCDDG program is the DNA repair enzyme DNA polymerase β. This enzyme serves an important protective role by participating in the repair of lesions to DNA caused by environmental and metabolic events. However, this enzyme is also believed to help repair the damage caused by agents employed as antitumor agents, such as bleomycin and cisplatin. In this sense, transient inhibition of the enzyme concomitant with antitumor therapy might improve the effectiveness of certain DNA damaging antitumor agents. Accordingly, we have been identifying naturally occurring inhibitors of DNA polymerase β. It is now known that there are two transformations mediated by polymerase β, namely a gap-filling polymerization from which the enzyme derives its name, as well as a lyase reaction that results in excision of the deoxyribose phosphate moiety at the site of the lesion. The lyase reaction is believed to be the rate-limiting step. This presentation summarizes the status of studies of identification of inhibitors of both activities.

KW - Adjuvant chemotherapy

KW - Base excision repair

KW - DNA polymerase β

KW - Lyase inhibitors

KW - Natural products

KW - Polymerase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=9444231143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9444231143&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:9444231143

VL - 41

SP - 68

EP - 77

JO - Pharmaceutical Biology

JF - Pharmaceutical Biology

SN - 1388-0209

IS - SUPPL.

ER -